UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography–tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2003-03, Vol.785 (2), p.263-275

2003

Volltextzugriff (PDF)

A convolution‐based in vitro‐in vivo correlation model for methylphenidate hydrochloride delayed‐release and extended‐release capsule

CPT: pharmacometrics and systems pharmacology, 2024-01, Vol.13 (1), p.132-142

2024

Volltextzugriff (PDF)

2.31 Effect of Delayed-Release and Extended-Release Methylphenidate (DR/ER-MPH) on All-Day and Early Morning ADHD-Related Symptoms: Analysis of ADHD-Rating Scale-IV and ADHD-AM-Rating Scale Items From a Phase 3 Trial

Journal of the American Academy of Child and Adolescent Psychiatry, 2018-10, Vol.57 (10), p.S169-S169

2018

Volltextzugriff (PDF)

4.23 PIVOTAL PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF HLD200, A NOVEL DELAYED-RELEASE AND EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE, IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Journal of the American Academy of Child and Adolescent Psychiatry, 2016-10, Vol.55 (10), p.S170-S170

2016

Volltextzugriff (PDF)

Development and Evaluation of a Solid-Phase Microextraction Probe for in Vivo Pharmacokinetic Studies

Analytical chemistry (Washington), 2003-10, Vol.75 (19), p.5103-5115

2003

Volltextzugriff (PDF)

5.12 ELECTRONICALLY MONITORED ADHERENCE RATES WITH EVENING-DOSED DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE IN CHILDREN WITH ADHD

Journal of the American Academy of Child and Adolescent Psychiatry, 2020-10, Vol.59 (10), p.S152-S153

2020

Volltextzugriff (PDF)

2.32 Development of an Interactive Pharmacokinetic Dose-Dependent Duration Model for Delayed-Release and Extended-Release Methylphenidate

Journal of the American Academy of Child and Adolescent Psychiatry, 2023-10, Vol.62 (10), p.S191-S191

2023

Volltextzugriff (PDF)

Pooled Post Hoc Analysis of Permanent Product Measure of Performance (PERMP) Scores in Children With ADHD Treated With DR/ER-MPH from Two Phase 3 Studies

Journal of the American Academy of Child and Adolescent Psychiatry, 2023-10, Vol.62 (10), p.S318-S318

2023

Volltextzugriff (PDF)

5.19 PERCEPTIONS OF ADHD THROUGHOUT THE DAY AMONG HEALTH CARE PROVIDERS, ADULT PATIENTS, AND CAREGIVERS OF DIAGNOSED CHILDREN AND ADOLESCENTS

Journal of the American Academy of Child and Adolescent Psychiatry, 2020-10, Vol.59 (10), p.S155-S155

2020

Volltextzugriff (PDF)

IMPROVEMENTS IN EMOTIONAL LABILITY WITH DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE TREATMENT IN CHILDREN WITH ADHD

Journal of the American Academy of Child and Adolescent Psychiatry, 2021-10, Vol.60 (10), p.S257-S257

2021

Volltextzugriff (PDF)

Model-Based Approach for Establishing the Predicted Clinical Response of a Delayed-Release and Extended-Release Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder

Journal of clinical psychopharmacology, 2020-07, Vol.40 (4), p.350-358

2020

Volltextzugriff (PDF)

Improvement in Functional Impairment During the Early Morning and Late Afternoon/Evening Bookends of the Day: Data from Two Phase 3 Trials of Evening-Dosed Delayed-Release and Extended-Release Methylphenidate in Children with ADHD

Pediatrics (Evanston), 2020-07, Vol.146 (1_MeetingAbstract), p.590-590

2020

Volltextzugriff (PDF)

Improvements in Early Morning and Late Afternoon/Evening Functional Impairment with Delayed-Release and Extended-Release Methylphenidate in Children with ADHD: Post Hoc Analysis of 2 Validated Scales by Norm-Referenced Cut-Offs

Pediatrics (Evanston), 2020-07, Vol.146 (1_MeetingAbstract), p.592-592

2020

Volltextzugriff (PDF)

Adverse Events During Dosing of Delayed-release/Extended-release Methylphenidate: Learnings From the Open-label Phase of a Registration Trial and a Real-world Postmarketing Surveillance Program

Clinical therapeutics, 2023-12, Vol.45 (12), p.1212-1221

2023

Volltextzugriff (PDF)

Quantitative Characterization of the Smoothness of Extended-release Methylphenidate Pharmacokinetic Profiles

Innovations in clinical neuroscience, 2022-07, Vol.19 (7-9), p.32-37

2022

Volltextzugriff (PDF)

Single-Dose Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate Formulation, in Healthy Adults and in Adolescents and Children with Attention-Deficit/Hyperactivity Disorder

Journal of child and adolescent psychopharmacology, 2018-02, Vol.28 (1), p.10-18

2018

Volltextzugriff (PDF)

5.21 POST HOC META-ANALYSIS OF MORNING AND EVENING BEHAVIORS IN CHILDREN WITH ADHD TREATED WITH DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE FROM TWO PHASE 3 STUDIES

Journal of the American Academy of Child and Adolescent Psychiatry, 2020-10, Vol.59 (10), p.S155-S156

2020

Volltextzugriff (PDF)

Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed‐Release and Extended‐Release Methylphenidate: In Vivo, In Vitro, and Modeling Evaluations

Clinical pharmacology in drug development, 2022-08, Vol.11 (8), p.966-975

2022

Volltextzugriff (PDF)

A Post Hoc Comparison of Prior ADHD Medication Dose and Optimized Delayed-release and Extended-release Methylphenidate Dose in a Pivotal Phase III Trial

Clinical therapeutics, 2020-12, Vol.42 (12), p.2332-2340

2020

Volltextzugriff (PDF)

6.48 CLINICAL RESPONSES AND SYMPTOMATIC REMISSIONS ACHIEVED WITH DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE IN CHILDREN WITH ADHD

Journal of the American Academy of Child and Adolescent Psychiatry, 2019-10, Vol.58 (10), p.S286-S287

2019

Volltextzugriff (PDF)

Normative Data for the Parent Rating of Evening and Morning Behavior Scale, Revised (PREMB-R) in Youth With and Without a History of Attention-Deficit/Hyperactivity Disorder

Pediatrics (Evanston), 2018-05, Vol.142 (1_MeetingAbstract), p.817-817

2018

Volltextzugriff (PDF)

Normative Data for the Before School Functioning Questionnaire (BSFQ) in Youth With and Without a History of Attention-Deficit/Hyperactivity Disorder

Pediatrics (Evanston), 2018-05, Vol.142 (1_MeetingAbstract), p.816-816

2018

Volltextzugriff (PDF)

Symptomatic and Functional Response and Remission From the Open-Label Treatment-Optimization Phase of a Study With DR/ER-MPH in Children With ADHD

The journal of clinical psychiatry, 2021-06, Vol.82 (4)

2021

Volltextzugriff (PDF)

31.8 REAL-WORLD SAFETY PROFILE OF DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE FOR ADHD IN CHILDREN, ADOLESCENTS, AND ADULTS

Journal of the American Academy of Child and Adolescent Psychiatry, 2020-10, Vol.59 (10), p.S213-S213

2020

Volltextzugriff (PDF)

Functional Impairment in Youth With ADHD: Normative Data and Norm-Referenced Cutoff Points for the Before School Functioning Questionnaire and the Parent Rating of Evening and Morning Behavior Scale, Revised

The journal of clinical psychiatry, 2019-12, Vol.81 (1)

2019

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(46)

Sprache

Englisch
(46)

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Life Sciences & Biomedicine
(19)
Methylphenidate
(16)
Attention Deficit Hyperactivity Disorder
(14)
Psychiatry
(11)
Pharmacology & Pharmacy
(10)
Attention-Deficit/hyperactivity Disorder
(9)
Hyperactivity
(9)
Children
(8)
Stimulants
(8)
Drug Dosages
(7)
Humans
(6)
Pediatrics
(6)
Pharmacokinetics
(6)
Attention Deficit Disorder With Hyperactivity - Drug Therapy
(5)
Clinical Trials
(5)
Double-Blind Studies
(5)
Original
(5)
Titration
(5)
Biological And Medical Sciences
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography–tandem mass spectrometry

A convolution‐based in vitro‐in vivo correlation model for methylphenidate hydrochloride delayed‐release and extended‐release capsule

2.31 Effect of Delayed-Release and Extended-Release Methylphenidate (DR/ER-MPH) on All-Day and Early Morning ADHD-Related Symptoms: Analysis of ADHD-Rating Scale-IV and ADHD-AM-Rating Scale Items From a Phase 3 Trial

4.23 PIVOTAL PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF HLD200, A NOVEL DELAYED-RELEASE AND EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE, IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Development and Evaluation of a Solid-Phase Microextraction Probe for in Vivo Pharmacokinetic Studies

5.12 ELECTRONICALLY MONITORED ADHERENCE RATES WITH EVENING-DOSED DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE IN CHILDREN WITH ADHD

2.32 Development of an Interactive Pharmacokinetic Dose-Dependent Duration Model for Delayed-Release and Extended-Release Methylphenidate

Pooled Post Hoc Analysis of Permanent Product Measure of Performance (PERMP) Scores in Children With ADHD Treated With DR/ER-MPH from Two Phase 3 Studies

5.19 PERCEPTIONS OF ADHD THROUGHOUT THE DAY AMONG HEALTH CARE PROVIDERS, ADULT PATIENTS, AND CAREGIVERS OF DIAGNOSED CHILDREN AND ADOLESCENTS

IMPROVEMENTS IN EMOTIONAL LABILITY WITH DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE TREATMENT IN CHILDREN WITH ADHD

Model-Based Approach for Establishing the Predicted Clinical Response of a Delayed-Release and Extended-Release Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder

Improvement in Functional Impairment During the Early Morning and Late Afternoon/Evening Bookends of the Day: Data from Two Phase 3 Trials of Evening-Dosed Delayed-Release and Extended-Release Methylphenidate in Children with ADHD

Improvements in Early Morning and Late Afternoon/Evening Functional Impairment with Delayed-Release and Extended-Release Methylphenidate in Children with ADHD: Post Hoc Analysis of 2 Validated Scales by Norm-Referenced Cut-Offs

Adverse Events During Dosing of Delayed-release/Extended-release Methylphenidate: Learnings From the Open-label Phase of a Registration Trial and a Real-world Postmarketing Surveillance Program

Quantitative Characterization of the Smoothness of Extended-release Methylphenidate Pharmacokinetic Profiles

Single-Dose Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate Formulation, in Healthy Adults and in Adolescents and Children with Attention-Deficit/Hyperactivity Disorder

5.21 POST HOC META-ANALYSIS OF MORNING AND EVENING BEHAVIORS IN CHILDREN WITH ADHD TREATED WITH DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE FROM TWO PHASE 3 STUDIES

Effect of Colonic Absorption on the Pharmacokinetic Properties of Delayed‐Release and Extended‐Release Methylphenidate: In Vivo, In Vitro, and Modeling Evaluations

A Post Hoc Comparison of Prior ADHD Medication Dose and Optimized Delayed-release and Extended-release Methylphenidate Dose in a Pivotal Phase III Trial

6.48 CLINICAL RESPONSES AND SYMPTOMATIC REMISSIONS ACHIEVED WITH DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE IN CHILDREN WITH ADHD

Normative Data for the Parent Rating of Evening and Morning Behavior Scale, Revised (PREMB-R) in Youth With and Without a History of Attention-Deficit/Hyperactivity Disorder

Normative Data for the Before School Functioning Questionnaire (BSFQ) in Youth With and Without a History of Attention-Deficit/Hyperactivity Disorder

Symptomatic and Functional Response and Remission From the Open-Label Treatment-Optimization Phase of a Study With DR/ER-MPH in Children With ADHD

31.8 REAL-WORLD SAFETY PROFILE OF DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE FOR ADHD IN CHILDREN, ADOLESCENTS, AND ADULTS

Functional Impairment in Youth With ADHD: Normative Data and Norm-Referenced Cutoff Points for the Before School Functioning Questionnaire and the Parent Rating of Evening and Morning Behavior Scale, Revised

Suchergebnisse filtern